Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes
Sinteza i fizičko‐hemijska karakterizacija tri novosintetisana derivata sulfhidroksamske kiseline kao potencijalnih dualnih inhibitora enzima ciklooksigenaze‐2 i 5‐lipooksigenaze
Conference object (Published version)
Metadata
Show full item recordAbstract
Inflammatory mediators derived from arachidonic acid by the enzymes
cyclooxygenase (COX) and lipoxygenase (LOX) are involved in the pathogenesis of various
inflammatory diseases. Inhibition of the COX pathway is thought to lead to potentiation of
the LOX pathway, and inhibition of both pathways represents a rational approach to the
design and development of more effective and safer anti-inflammatory drugs (1). The aim of
this study was the synthesis and physico-chemical characterization of 1f, 1g and 1h
derivatives derived from a previously conducted 3D-QSAR study and molecular docking (2).
The sulfhydroxamic acid derivative 1f was synthesized in a two-step process. Sulfonyl
chloride was synthesized from commercially available sulfonic acid and thionyl chloride in
the presence of a catalytic amount of DMF. Sulfhydroxamic acid was further obtained from
previously synthesized sulfonyl chloride and hydroxylamine hydrochloride in the presence
of 10% NaHCO3 solution. Sulfhydroxam...ic acid derivatives, 1g and 1h were synthesized from
commercially available sulfonyl chlorides and hydroxylamine hydrochloride in the presence
of 10% NaHCO3 solution. The reaction mixtures were purified by liquid-liquid extraction and
preparative TLC to give derivatives 1f, 1g, 1h in yields: 26%, 53% and 63%. The structure
and purity of the synthesized compounds were confirmed by determination of the melting
points and spectroscopic techniques (ATR-FTIR, 1H-NMR, 13C-NMR, MS/MS). Based on a
previously conducted in silico study, the voluminous sulfhydroxamic group is responsible for
iron chelation within 5-LOX active center and for COX-2 selectivity, as COX-2 has wider side
pocket, so potent inhibition of COX-2 and 5-LOX enzymes is expected.
Inflamatorni medijatori koji nastaju iz arahidonske kiseline posredstvom enzima
ciklooksigenaze (COX) i lipooksigenaze (LOX) učestvuju u patogenezi brojnih inflamatornih
oboljenja. Smatra se da inhibicija COX puta dovodi do potenciranja LOX puta, te inhibicija oba
puta predstavlja racionalan pristup dizajniranja i razvoja novih, efikasnijih i bezbednijih
antiinflamatornih lekova (1). Cilj rada je bila sinteza i fizičko-hemijska karakterizacija
derivata 1f, 1g i 1h proisteklih iz prethodno sprovedene 3D-QSAR studije i molekulskog
docking-a (2). Derivat sulfhidroksamske kiseline 1f je sintetisan u dvostepenom postupku pri
čemu se najpre iz komercijalno dostupne sulfonske kiseline i tionil hlorida u prisustvu
katalitičke količine DMF dobija odgovarajući sulfonil hlorid. Odgovarajuća sulfhidroksamska
kiselina (1f) se dobija u drugom koraku iz prethodno sintetisanog sulfonil hlorida i
hidroksilamin-hidrohlorida u prisustvu 10% rastvora NaHCO3 . Derivati sulfhidroksamske
kiseline,... 1g i 1h su sintetisani jednostepenim postupkom iz komercijalno dostupnih sulfonil
hlorida i hidroksilamin-hidrohlorida u prisustvu 10% rastvora NaHCO3 . Nakon postupka
sinteze jedinjenja su prečišćena tečno-tečnom ekstrakcijom i preparativnom TLC pri čemu se
dobijaju derivati 1f, 1g, 1h u prinosima 26%, 53% i 63%. Struktura i čistoća sintetisanih
jedinjenja je potvrđena određivanjem temperature topljenja i spektroskopskim (ATR-FTIR,
1 H-NMR, 13 C-NMR, MS/MS) tehnikama. Na osnovu prethodno sprovedene in silico studije,
voluminozni centar i sulfhidroksamska grupa sintetisanih derivata su odgovorni za COX-2
selektivnost zbog prisustva šireg vezivnog mesta unutar COX-2 enzima, dok
sulfhidroksamska grupa unutar 5-LOX enzima helira gvožđe aktivnog centra i inhibira enzim,
te se očekuje potentna dualna COX-2 i 5-LOX inhibitorna aktivnost sintetisanih derivata.
Source:
Arhiv za farmaciju, 2022, 72, 4 suplement, S524-S525Publisher:
- Savez farmaceutskih udruženja Srbije (SFUS)
Funding / projects:
Note:
- VIII Kongres farmaceuta Srbije sa međunarodnim učešćem, 12-15.10.2022. Beograd
Collections
Institution/Community
PharmacyTY - CONF AU - Bošković, Jelena AU - Čudina, Olivera AU - Dobričić, Vladimir PY - 2022 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4595 AB - Inflammatory mediators derived from arachidonic acid by the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) are involved in the pathogenesis of various inflammatory diseases. Inhibition of the COX pathway is thought to lead to potentiation of the LOX pathway, and inhibition of both pathways represents a rational approach to the design and development of more effective and safer anti-inflammatory drugs (1). The aim of this study was the synthesis and physico-chemical characterization of 1f, 1g and 1h derivatives derived from a previously conducted 3D-QSAR study and molecular docking (2). The sulfhydroxamic acid derivative 1f was synthesized in a two-step process. Sulfonyl chloride was synthesized from commercially available sulfonic acid and thionyl chloride in the presence of a catalytic amount of DMF. Sulfhydroxamic acid was further obtained from previously synthesized sulfonyl chloride and hydroxylamine hydrochloride in the presence of 10% NaHCO3 solution. Sulfhydroxamic acid derivatives, 1g and 1h were synthesized from commercially available sulfonyl chlorides and hydroxylamine hydrochloride in the presence of 10% NaHCO3 solution. The reaction mixtures were purified by liquid-liquid extraction and preparative TLC to give derivatives 1f, 1g, 1h in yields: 26%, 53% and 63%. The structure and purity of the synthesized compounds were confirmed by determination of the melting points and spectroscopic techniques (ATR-FTIR, 1H-NMR, 13C-NMR, MS/MS). Based on a previously conducted in silico study, the voluminous sulfhydroxamic group is responsible for iron chelation within 5-LOX active center and for COX-2 selectivity, as COX-2 has wider side pocket, so potent inhibition of COX-2 and 5-LOX enzymes is expected. AB - Inflamatorni medijatori koji nastaju iz arahidonske kiseline posredstvom enzima ciklooksigenaze (COX) i lipooksigenaze (LOX) učestvuju u patogenezi brojnih inflamatornih oboljenja. Smatra se da inhibicija COX puta dovodi do potenciranja LOX puta, te inhibicija oba puta predstavlja racionalan pristup dizajniranja i razvoja novih, efikasnijih i bezbednijih antiinflamatornih lekova (1). Cilj rada je bila sinteza i fizičko-hemijska karakterizacija derivata 1f, 1g i 1h proisteklih iz prethodno sprovedene 3D-QSAR studije i molekulskog docking-a (2). Derivat sulfhidroksamske kiseline 1f je sintetisan u dvostepenom postupku pri čemu se najpre iz komercijalno dostupne sulfonske kiseline i tionil hlorida u prisustvu katalitičke količine DMF dobija odgovarajući sulfonil hlorid. Odgovarajuća sulfhidroksamska kiselina (1f) se dobija u drugom koraku iz prethodno sintetisanog sulfonil hlorida i hidroksilamin-hidrohlorida u prisustvu 10% rastvora NaHCO3 . Derivati sulfhidroksamske kiseline, 1g i 1h su sintetisani jednostepenim postupkom iz komercijalno dostupnih sulfonil hlorida i hidroksilamin-hidrohlorida u prisustvu 10% rastvora NaHCO3 . Nakon postupka sinteze jedinjenja su prečišćena tečno-tečnom ekstrakcijom i preparativnom TLC pri čemu se dobijaju derivati 1f, 1g, 1h u prinosima 26%, 53% i 63%. Struktura i čistoća sintetisanih jedinjenja je potvrđena određivanjem temperature topljenja i spektroskopskim (ATR-FTIR, 1 H-NMR, 13 C-NMR, MS/MS) tehnikama. Na osnovu prethodno sprovedene in silico studije, voluminozni centar i sulfhidroksamska grupa sintetisanih derivata su odgovorni za COX-2 selektivnost zbog prisustva šireg vezivnog mesta unutar COX-2 enzima, dok sulfhidroksamska grupa unutar 5-LOX enzima helira gvožđe aktivnog centra i inhibira enzim, te se očekuje potentna dualna COX-2 i 5-LOX inhibitorna aktivnost sintetisanih derivata. PB - Savez farmaceutskih udruženja Srbije (SFUS) C3 - Arhiv za farmaciju T1 - Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes T1 - Sinteza i fizičko‐hemijska karakterizacija tri novosintetisana derivata sulfhidroksamske kiseline kao potencijalnih dualnih inhibitora enzima ciklooksigenaze‐2 i 5‐lipooksigenaze VL - 72 IS - 4 suplement SP - S524 EP - S525 UR - https://hdl.handle.net/21.15107/rcub_farfar_4595 ER -
@conference{ author = "Bošković, Jelena and Čudina, Olivera and Dobričić, Vladimir", year = "2022", abstract = "Inflammatory mediators derived from arachidonic acid by the enzymes cyclooxygenase (COX) and lipoxygenase (LOX) are involved in the pathogenesis of various inflammatory diseases. Inhibition of the COX pathway is thought to lead to potentiation of the LOX pathway, and inhibition of both pathways represents a rational approach to the design and development of more effective and safer anti-inflammatory drugs (1). The aim of this study was the synthesis and physico-chemical characterization of 1f, 1g and 1h derivatives derived from a previously conducted 3D-QSAR study and molecular docking (2). The sulfhydroxamic acid derivative 1f was synthesized in a two-step process. Sulfonyl chloride was synthesized from commercially available sulfonic acid and thionyl chloride in the presence of a catalytic amount of DMF. Sulfhydroxamic acid was further obtained from previously synthesized sulfonyl chloride and hydroxylamine hydrochloride in the presence of 10% NaHCO3 solution. Sulfhydroxamic acid derivatives, 1g and 1h were synthesized from commercially available sulfonyl chlorides and hydroxylamine hydrochloride in the presence of 10% NaHCO3 solution. The reaction mixtures were purified by liquid-liquid extraction and preparative TLC to give derivatives 1f, 1g, 1h in yields: 26%, 53% and 63%. The structure and purity of the synthesized compounds were confirmed by determination of the melting points and spectroscopic techniques (ATR-FTIR, 1H-NMR, 13C-NMR, MS/MS). Based on a previously conducted in silico study, the voluminous sulfhydroxamic group is responsible for iron chelation within 5-LOX active center and for COX-2 selectivity, as COX-2 has wider side pocket, so potent inhibition of COX-2 and 5-LOX enzymes is expected., Inflamatorni medijatori koji nastaju iz arahidonske kiseline posredstvom enzima ciklooksigenaze (COX) i lipooksigenaze (LOX) učestvuju u patogenezi brojnih inflamatornih oboljenja. Smatra se da inhibicija COX puta dovodi do potenciranja LOX puta, te inhibicija oba puta predstavlja racionalan pristup dizajniranja i razvoja novih, efikasnijih i bezbednijih antiinflamatornih lekova (1). Cilj rada je bila sinteza i fizičko-hemijska karakterizacija derivata 1f, 1g i 1h proisteklih iz prethodno sprovedene 3D-QSAR studije i molekulskog docking-a (2). Derivat sulfhidroksamske kiseline 1f je sintetisan u dvostepenom postupku pri čemu se najpre iz komercijalno dostupne sulfonske kiseline i tionil hlorida u prisustvu katalitičke količine DMF dobija odgovarajući sulfonil hlorid. Odgovarajuća sulfhidroksamska kiselina (1f) se dobija u drugom koraku iz prethodno sintetisanog sulfonil hlorida i hidroksilamin-hidrohlorida u prisustvu 10% rastvora NaHCO3 . Derivati sulfhidroksamske kiseline, 1g i 1h su sintetisani jednostepenim postupkom iz komercijalno dostupnih sulfonil hlorida i hidroksilamin-hidrohlorida u prisustvu 10% rastvora NaHCO3 . Nakon postupka sinteze jedinjenja su prečišćena tečno-tečnom ekstrakcijom i preparativnom TLC pri čemu se dobijaju derivati 1f, 1g, 1h u prinosima 26%, 53% i 63%. Struktura i čistoća sintetisanih jedinjenja je potvrđena određivanjem temperature topljenja i spektroskopskim (ATR-FTIR, 1 H-NMR, 13 C-NMR, MS/MS) tehnikama. Na osnovu prethodno sprovedene in silico studije, voluminozni centar i sulfhidroksamska grupa sintetisanih derivata su odgovorni za COX-2 selektivnost zbog prisustva šireg vezivnog mesta unutar COX-2 enzima, dok sulfhidroksamska grupa unutar 5-LOX enzima helira gvožđe aktivnog centra i inhibira enzim, te se očekuje potentna dualna COX-2 i 5-LOX inhibitorna aktivnost sintetisanih derivata.", publisher = "Savez farmaceutskih udruženja Srbije (SFUS)", journal = "Arhiv za farmaciju", title = "Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes, Sinteza i fizičko‐hemijska karakterizacija tri novosintetisana derivata sulfhidroksamske kiseline kao potencijalnih dualnih inhibitora enzima ciklooksigenaze‐2 i 5‐lipooksigenaze", volume = "72", number = "4 suplement", pages = "S524-S525", url = "https://hdl.handle.net/21.15107/rcub_farfar_4595" }
Bošković, J., Čudina, O.,& Dobričić, V.. (2022). Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes. in Arhiv za farmaciju Savez farmaceutskih udruženja Srbije (SFUS)., 72(4 suplement), S524-S525. https://hdl.handle.net/21.15107/rcub_farfar_4595
Bošković J, Čudina O, Dobričić V. Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes. in Arhiv za farmaciju. 2022;72(4 suplement):S524-S525. https://hdl.handle.net/21.15107/rcub_farfar_4595 .
Bošković, Jelena, Čudina, Olivera, Dobričić, Vladimir, "Synthesis and physicochemical characterization of three newly synthesized sulfhydroxamic acid derivatives as potential dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes" in Arhiv za farmaciju, 72, no. 4 suplement (2022):S524-S525, https://hdl.handle.net/21.15107/rcub_farfar_4595 .